Teva buys Allergan: 3 reasons why it's a blockbuster deal | Fortune
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva's deal with Allergan continues a massive year for pharma M&A — Quartz
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw Pressure - WSJ
Teva investors fret over $41bn generic drugs deal | Financial Times
Teva Pharmaceuticals Announces $40.5 Billion Deal For Allergan's Generic Drug Unit
Allergan to sell a quarter of its Teva stake in first quarter of 2018 | Reuters
Mayne vaults ahead in U.S. with $652M deal for Teva/Allergan meds | Fierce Pharma
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva buys Allergan's generic drug unit for $40.5B
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Allergan Merger
Birth Of A Giant: A Timeline Of Teva And Allergan's Generics Business :: Pink Sheet
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
Dr Reddy's in $350 million deal to buy 8 US drugs from Teva, Allergan - Times of India
Teva wants Allergan's distribution biz now that $40B drug deal has closed | Fierce Pharma
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
